Aptadir Therapeutics
CompanyMilan, Italy· Biotech
Italian biotech developing RNA medicines that reactivate silenced genes.
Minutes holds 1 development and 1 deal naming Aptadir Therapeutics, recorded from September 2026.
Intelligence
Investors in rounds covered by Minutes
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Aptadir TherapeuticsBiotech | FundingSeed | €40M | Led by 4BIO CapitalWith EXTEND | 29 Sep | Closed |